International Coalition of Medicines Regulatory Authorities (ICMRA)
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, executive-level entity focused on strategic coordination, advocacy, and leadership among regulatory authorities. Its mission is to provide a global architecture that supports enhanced communication, information sharing, and crisis response, while also addressing regulatory science issues. ICMRA aims to tackle current and emerging human medicine regulatory and safety challenges on a global scale. The organization is designed to facilitate collaboration and streamline responses to critical issues within the field of medicine regulation. The website itself was designed by Swissmedic and is maintained by the Pharmaceuticals and Medical Devices Agency, indicating a collaborative effort in its operational infrastructure.
About
**Who they are** Swiss Medical Regulatory is an entity associated with the International Coalition of Medicines Regulatory Authorities (ICMRA), which serves as a strategic coordinating body for regulatory authorities globally. The website content indicates that the ICMRA Secretariat can be contacted via email, and the website itself was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
**Expertise & scope** * Facilitates global communication and information sharing among medicines regulatory authorities. * Enhances crisis response capabilities for medicines. * Addresses current and emerging human medicine regulatory and safety challenges globally and strategically. * Supports the addressing of regulatory science issues.
**Reputation / proof points** * The ICMRA website is designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
Additional information
The International Coalition of Medicines Regulatory Authorities (ICMRA) operates as a collaborative platform for regulatory bodies. Its activities focus on enhancing international cooperation, sharing critical information, and coordinating responses to global health crises related to medicines. The organization's structure and initiatives are guided by its participating regulatory authorities, with a focus on addressing both current and emerging challenges in medicine regulation and safety.
Key Highlights
The ICMRA Secretariat can be contacted at ICMRASecretariat@health.gov.au.
Source
“ICMRA Secretariat can be contacted at ICMRASecretariat@health.gov.au.”
The website was designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency.
Source
“Website designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency”
Professor Anthony (Tony) Lawler began his mandate as ICMRA Chair on 23 October 2025.
Source
“The Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) is Professor Anthony (Tony) Lawler. He began his mandate as ICMRA Chair on 23 October 2025.”
Certifications & Trust Signals
The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities.
Source
“The International Coalition of Medicines Regulatory Authorities (ICMRA) is a strategic coordinating entity for regulatory authorities, enhancing global communication, information sharing, and crisis response for medicines.”
Buyer Snapshot
Best for
Entities seeking international regulatory coordination insights
Organizations interested in global medicines regulation
How engagement typically works
Information-based engagement through website content
Collaboration with international regulatory authorities
Typical deliverables
Insights into global regulatory strategies
Information on international crisis response for medicines
Good to know
Best when buyer is seeking information on international regulatory bodies rather than direct Swiss representation services.
HQ: Geneva, Switzerland
Languages: English, German, French
Timezones: Europe/Zurich
Claim status: Listed
Services & Capabilities
Find CH-REP (Swiss Authorized Rep) | Compare & Get Quotes
Jurisdictions: CH
Countries: CH
Industries: Medical devices, IVD
Portfolio: 6-25
Onboarding time: 3–10 days
Pricing model: Custom pricing
Starting from: CHF 2,100
Included services: Swissmedic contact point handling, Vigilance and incident reporting coordination, Labeling/packaging CH-REP information alignment, Mandate administration and documentation availability